http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010090078-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553 |
| filingDate | 2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1db653734a3615490d9bd92ddf2a627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fd7c5bbbe578bc5f7ce0d3c77038df2 |
| publicationDate | 2010-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010090078-A |
| titleOfInvention | Tricyclic heteroaryl derivatives |
| abstract | Hyperlipidemia such as hypercholesterolemia, hypertriglyceridemia, hypoHDLemia and the like for mammals including humans, exhibiting squalene synthase inhibitory activity, cholesterol synthesis inhibitory activity and low toxicity The provision of a compound useful as a pharmaceutical agent such as a prophylactic and / or therapeutic agent for arteriosclerosis. (1) [(4R, 6R) -8-chloro-6- (2-cyano-3-ethoxyphenyl) -1- (trifluoromethyl) -4H, 6H- [1,2,4] Triazolo [4,3-a] [4,1] benzoxazepin-4-yl] acetic acid (2) [(4R, 6R) -8-chloro-1- [chloro (difluoro) methyl] -6 -(2-cyano-3-methoxyphenyl) -4H, 6H- [1,2,4] triazolo [4,3-a] [4,1] benzoxazepin-4-yl] acetic acid, etc. Specific compound. [Selection figure] None |
| priorityDate | 2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 295.